Federal Register: July 1, 2009 (Volume 74, Number 125)
DOCID: fr01jy09-70 FR Doc E9-15568
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
NOTICE: NOTICES
DOCID: fr01jy09-70
ACTION: Meetings:
SUBJECT CATEGORY:
National Human Genome Research Institute; Notice of Closed Meeting
DOCUMENT SUMMARY:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute Special Emphasis Panel, RC2 Sequencing Technology.
Date: July 27, 2009.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Plaza Hotel, 10 Thomas Circle, NW., Washington, DC 20005.
Contact Person: Ken D. Nakamura, PhD, Scientific Review Officer,
Scientific Review Branch, National Human Genome Research Institute,
National Institutes of Health, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, 3014020838, nakamurk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)
Dated: June 24, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. E915568 Filed 63009; 8:45 am]
BILLING CODE 414001P
SUMMARY:
National Human Genome Research Institute,
DOCUMENT BODY 2:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute Special Emphasis Panel, RC2 Sequencing Technology.
Date: July 27, 2009.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Plaza Hotel, 10 Thomas Circle, NW., Washington, DC 20005.
Contact Person: Ken D. Nakamura, PhD, Scientific Review Officer,
Scientific Review Branch, National Human Genome Research Institute,
National Institutes of Health, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, 3014020838, nakamurk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)
Dated: June 24, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. E915568 Filed 63009; 8:45 am]
BILLING CODE 414001P